BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
419273
Number of visits today
42
Number of downloads
121512
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Pereira-Veiga T, Schneegans S, Pantel K, Wikman H. Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance. Cell Rep 2022;40:111298. [PMID: 36044866 DOI: 10.1016/j.celrep.2022.111298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Georgakopoulos-Soares I, Ahituv N, Wong KC. Risk scoring based on DNA methylation-driven related DEGs for colorectal cancer prognosis with systematic insights. Life Sci 2023;316:121413. [PMID: 36682524 DOI: 10.1016/j.lfs.2023.121413] [Reference Citation Analysis]
2 Bates M, Mohamed BM, Ward MP, Kelly TE, O'Connor R, Malone V, Brooks R, Brooks D, Selemidis S, Martin C, O'Toole S, O'Leary JJ. Circulating tumour cells: The Good, the Bad and the Ugly. Biochim Biophys Acta Rev Cancer 2023;1878:188863. [PMID: 36796527 DOI: 10.1016/j.bbcan.2023.188863] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Park CK, Lee SW, Cho HJ, Oh HJ, Kim YC, Kim YH, Ahn SJ, Cho JH, Oh IJ. Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer. Cancers (Basel) 2023;15. [PMID: 36831494 DOI: 10.3390/cancers15041151] [Reference Citation Analysis]
4 Lu Z, Huang Y, Huang J, Ni HH, Luo T, Wei X, Bai X, Qi L, Xiang B. High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells. J Hepatocell Carcinoma 2023;10:57-68. [PMID: 36685111 DOI: 10.2147/JHC.S398591] [Reference Citation Analysis]
5 Nitschke C, Markmann B, Konczalla L, Kropidlowski J, Pereira-Veiga T, Scognamiglio P, Schönrock M, Sinn M, Tölle M, Izbicki J, Pantel K, Uzunoglu FG, Wikman H. Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma. Biomedicines 2022;10. [PMID: 36428523 DOI: 10.3390/biomedicines10112955] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345